b
r
c
part
group
interferonstimul
gene
play
import
role
differ
viral
infect
induc
cell
activ
chemotaxi
lymphocyt
prime
toward
phenotyp
studi
investig
vitro
effect
activ
human
primari
lymphocyt
term
apoptosi
surviv
delin
signal
pathway
involv
combin
andor
ifna
induc
apoptosi
lymphocyt
moreov
activ
also
trigger
prosurviv
signal
block
pertussi
toxin
analysi
downstream
signal
kinas
show
apoptosi
mapkdepend
prosurviv
signal
reli
sustain
activ
transient
activ
akt
hand
transient
activ
erk
impact
lymphocyt
surviv
propos
immunolog
model
togeth
costimul
cytokin
particip
activ
lymphocyt
promot
surviv
expans
certain
lymphocyt
subset
induc
chemotaxi
toward
infect
tissu
hand
might
contribut
trigger
apoptosi
subset
lymphocyt
includ
lymphocyt
transient
activ
later
lack
appropri
set
specif
costimul
signal
ensur
surviv
ifncinduc
protein
kda
play
import
role
viral
infect
influenza
sar
coronaviru
hiv
west
nile
viru
although
initi
identifi
ifncrespons
gene
number
differ
cytokin
includ
ifnab
capabl
induc
express
divers
cell
type
chemokin
mig
itac
bind
receptor
exert
potent
chemotact
effect
activ
lymphocyt
howev
one
play
promin
role
antivir
respons
express
normal
blood
cell
express
enhanc
treatment
addit
express
cell
type
natur
killer
cell
nk
eosinophil
b
lymphocyt
differ
epitheli
endotheli
cell
type
receptor
coupl
g
proteinsign
pathway
bind
chemokin
activ
g
proteinmedi
signal
result
downstream
activ
phospholipas
c
plc
kinas
c
format
phosphatidyl
also
increas
intracellular
calcium
ion
despit
function
divers
cell
express
downstream
activ
seem
quit
homogen
involv
erk
akt
howev
effect
activ
divers
rang
chemotaxi
lymphocyt
airway
epitheli
cell
antiprolifer
human
embryon
kidney
cell
induct
apoptosi
acinar
cell
program
cell
death
apoptosi
activ
process
morpholog
character
shrinkag
cell
nuclear
fragment
chromatin
condens
chromosom
dna
fragment
apoptosi
play
essenti
role
tissu
develop
requir
maintain
tissu
homeostasi
although
apoptosi
trigger
mani
differ
stimuli
execution
caspas
alway
particip
organ
degrad
cellular
organel
activ
execution
caspas
cleav
varieti
cytoplasm
nuclear
protein
includ
caspas
downstream
substrat
control
proteolysi
induct
apoptosi
tightli
regul
process
balanc
prosurviv
proapoptosi
signal
eventu
determin
fate
cell
vlahaki
et
al
shown
g
proteincoupl
chemokin
receptor
activ
surviv
apoptot
signal
pathway
report
trigger
apoptosi
sever
cellular
model
acinar
cell
neuron
hela
cell
microvascular
endotheli
cell
howev
role
determin
surviv
death
blood
lymphocyt
remain
larg
unknown
studi
delin
critic
signal
pathway
activ
receptor
demonstr
abl
transient
activ
akt
erk
signal
cascad
sustain
activ
mapk
signal
primari
human
lymphocyt
moreov
determin
role
pathway
induct
either
apoptosi
cell
surviv
monoclon
antibodi
mab
mous
antihuman
akt
mous
antihuman
phosphoakt
mous
antihuman
mous
antihuman
mous
antihuman
actin
obtain
bd
bioscienc
san
diego
ca
usa
mous
antihuman
rabbit
antihuman
rabbit
antihuman
erk
rabbit
antihuman
erk
rabbit
antihuman
rabbit
antihuman
rabbit
antihuman
caspas
cleav
obtain
cell
signal
technolog
boston
usa
sybr
green
pcr
master
mix
obtain
appli
biosystem
foster
citi
ca
usa
goat
antimous
igghrp
donkey
antirabbit
igghrp
purchas
santa
cruz
biotechnolog
santa
cruz
ca
usa
recombin
ifna
protein
purchas
r
system
minneapoli
mn
supplement
mm
lglutamin
hepe
buffer
solut
wv
gentamycin
obtain
gibco
brl
burlington
ontario
canada
fetal
calf
serum
fc
purchas
cansera
rexdal
ontario
canada
heatinactiv
min
upon
arriv
inhibitor
wortmannin
phosphatebuff
salin
pb
ph
pertussi
toxin
obtain
sigma
aldrich
inc
oakvil
ontario
canada
mek
inhibitor
inhibitor
purchas
biosourc
intern
inc
camarillo
ca
usa
blood
obtain
healthi
donor
age
rang
year
old
densiti
gradient
centrifug
use
separ
pbmc
human
blood
first
approxim
ml
blood
collect
brachial
vein
healthi
human
volunt
use
needl
steril
ml
syring
contain
unit
sodium
heparin
bectondickinson
mississauga
ontario
per
ml
blood
next
ml
steril
pb
contain
penicillin
streptomycin
penstrep
gibco
brl
ml
pb
ad
ml
blood
steril
ml
centrifug
tube
tube
underlay
ml
steril
ficollhypaqu
sigmaaldrich
inc
centrifug
g
min
room
temperatur
use
transfer
pipett
approxim
ml
plasma
remov
discard
use
fresh
steril
transfer
pipett
pbmc
layer
transfer
fresh
ml
tube
tube
tilt
angl
facilit
remov
pbmc
layer
ml
pbspenstrep
ad
isol
pbmc
pbmc
sampl
centrifug
g
min
supernat
discard
result
cell
pellet
gentli
resuspend
approxim
ml
pbspenstrep
ml
steril
distil
water
ad
swirl
maximum
lyse
rbc
final
ml
pb
immedi
ad
resuspend
cell
centrifug
min
g
remov
lyse
rbc
remain
ficol
studi
express
lymphocyt
separ
pbmc
magnet
bead
posit
select
use
monocyt
isol
kit
ii
miltenyi
biotech
auburn
ca
experi
untouch
lymphocyt
separ
pbmc
use
pan
cell
isol
kit
ii
miltenyi
cell
resuspend
pb
centrifug
min
g
supernat
discard
cell
resuspend
ml
complet
medium
supplement
heat
inactiv
fc
mm
lglutamin
fisher
scientif
nepean
ontario
canada
mm
bmercaptoethanol
fisher
scientif
penstrep
cell
count
use
unopett
becton
dickinson
compani
franklin
lake
nj
usa
hemocytomet
desir
cell
concentr
prepar
dilut
complet
rpmi
medium
induc
express
lymphocyt
cultur
day
complet
rpmi
medium
differ
combin
uml
ifna
uml
nm
cell
receiv
cytokin
retreat
everi
day
select
cell
cultur
preincub
hour
inhibitor
pertussi
toxin
lgml
wortmannin
nm
lm
lm
addit
ifna
experi
perform
triplic
lymphocyt
cell
pellet
centrifug
resuspend
bsa
pb
aliquot
fac
tube
incub
antibodi
min
dark
detect
apoptot
cell
sampl
incub
annexin
vpe
buffer
contain
bd
bioscienc
san
diego
ca
analyz
fac
stain
cell
wash
ml
pb
fix
paraformaldehyd
pb
analyz
use
duallas
flow
cytomet
fac
calibur
becton
dickinson
san
jose
ca
cellquest
softwar
bd
bioscienc
postacquisit
cytometri
data
analyz
use
flowjo
v
treestar
inc
ashland
day
cultur
cell
pellet
centrifug
g
lyse
addit
ml
trizol
reagent
invitrogen
canada
per
cell
rna
extract
accord
manufactur
protocol
concentr
rna
measur
optic
densiti
od
nm
use
eppendorf
biophotomet
mississauga
ontario
canada
integr
qualiti
total
rna
confirm
rnasefre
agaros
gel
electrophoresi
use
depctreat
tae
buffer
quantit
real
timepcr
qrtpcr
perform
use
abipr
sequenc
detect
system
sybr
green
pcr
master
mix
appli
biosystem
foster
citi
california
total
rna
qrtpcr
reaction
perform
volum
cdna
primer
pair
sybr
green
pcr
master
mix
abipr
optic
well
plate
primer
pair
design
gener
intronspan
product
approxim
bp
use
primer
express
softwar
appli
biosystem
primer
pair
test
logarithm
dilut
cdna
gener
standard
curv
use
calcul
start
quantiti
target
rna
primer
specif
rrna
use
endogen
standard
normal
sampl
foldchang
calcul
divid
normal
posttreat
sampl
quantiti
normal
pretreat
control
quantiti
sequenc
primer
pair
follow
acg
tgt
tga
gat
cat
tgc
reversetct
tga
tgg
cct
tcg
att
ctg
cta
cca
cat
cca
agg
aa
reversegct
gga
att
acc
gcg
gct
lymphocyt
cultur
well
plate
follow
treatment
indic
respect
figur
legend
fig
supp
fig
reaction
termin
centrifug
follow
supernat
aspir
cell
resuspens
icecold
lysi
buffer
mm
tri
ph
mm
nacl
mm
mgcl
mm
cacl
glycerol
wv
nonidet
wv
proteas
inhibitor
mm
pmsf
lgml
aprotinin
lgml
leupeptin
lgml
pepstatin
tyrosin
phosphotas
inhibitor
mm
sodium
orthovanad
lysat
incub
rotat
min
nonsolubl
materi
remov
fig
express
human
cell
enhanc
induc
lymphocyt
purifi
healthi
donor
pbmc
use
magnet
bead
posit
select
monocyt
isol
kit
ii
miltenyi
biotech
cultur
absenc
presenc
b
absenc
c
presenc
phenotyp
flow
cytometri
analysi
perform
assess
express
protein
level
percentag
cell
gate
viabl
cell
popul
indic
within
panel
cutoff
determin
neg
control
obtain
isotypematch
control
antibodi
conjug
pe
result
repres
three
independ
experi
gate
base
isotyp
control
centrifug
rpm
min
protein
level
supernat
determin
bradford
protein
assay
biorad
adjust
equal
protein
concentr
sampl
dilut
lysi
buffer
cell
lysat
boil
min
laemmli
buffer
sampl
load
onto
sdspage
gel
biorad
protein
separ
electrophoresi
protein
transfer
onto
nitrocellulos
membran
semidri
electroblot
immunoblot
perform
previous
describ
briefli
membran
incub
hour
block
solut
nonfat
sodium
azid
tb
mm
tri
ph
mm
nacl
incub
overnight
requir
dilut
appropri
primari
antibodi
wash
twice
membran
incub
goat
antimous
donkey
antirabbit
horseradish
peroxidaseconjug
secondari
antibodi
protein
band
detect
enhanc
chemiluminesc
ecl
amershampharmacia
biotech
directli
quantifi
use
imag
station
biorad
hercul
ca
necessari
membran
strip
reprob
incub
strip
buffer
mm
tri
ph
sd
mm
room
temperatur
min
examin
effect
express
human
primari
lymphocyt
use
flow
cytometri
found
express
untreat
lymphocyt
howev
rule
possibl
express
level
alter
extent
initi
process
posit
cell
select
upon
treatment
primari
lymphocyt
show
greatli
enhanc
express
increas
express
occur
popul
cell
fig
b
e
howev
incub
alter
express
level
fig
e
also
show
express
induc
concentr
ifna
uml
neither
cell
supp
fig
use
real
time
pcr
show
induc
ifna
primari
lymphocyt
human
embryon
kidney
cell
supp
fig
ensur
lymphocyt
respons
ifna
experiment
condit
examin
rate
cell
death
induc
primari
lymphocyt
incub
alon
nm
h
fac
analysi
cell
stain
annexin
v
demonstr
treatment
cell
recombin
induc
earli
apoptosi
annexin
v
posit
neg
although
limit
extent
fig
furthermor
preincub
cell
uml
increas
express
apoptosi
rate
fig
c
enhanc
earli
apoptosi
dramat
fig
cell
incub
ifna
alon
uml
also
lead
cell
earli
apoptosi
moreov
highest
rate
earli
apoptosi
observ
simultan
treatment
ifna
fig
cytokin
treatment
test
also
produc
increas
necrosi
rate
annexin
v
posit
posit
parallel
observ
rate
earli
apoptosi
fig
b
determin
whether
cell
death
analyz
whole
cell
lysat
lymphocyt
treat
ifna
presenc
activ
treat
ifna
analyz
fac
apoptosi
c
primari
lymphocyt
treat
ifna
analyz
fac
apoptosi
use
bd
annexinv
apoptosi
detect
kit
statist
signific
respect
isotyp
control
p
p
respect
p
p
respect
ifna
p
gate
base
isotyp
control
activ
mapk
lymphocyt
induc
activ
caspas
protein
extract
deriv
lysat
cell
treat
differ
combin
ifna
subject
western
blot
analysi
use
antibodi
recogn
fulllength
cleav
caspas
protein
level
actin
examin
load
control
cleav
fragment
assess
western
blot
use
antibodi
recogn
procaspas
cleav
shown
fig
independ
treatment
ifna
result
appreci
overexpress
cleavag
combin
treatment
ifna
caus
highest
level
activ
close
follow
interestingli
treatment
ifna
also
result
activ
elucid
signal
pathway
respons
apoptosi
studi
phosphoryl
differ
mapk
kinas
essenti
signal
mediat
lead
cell
toward
apoptosi
surviv
first
examin
put
role
activ
mapk
activ
lymphocyt
flow
cytometr
analysi
use
phosphospecif
antibodi
western
blot
fig
found
treatment
result
rapid
sustain
phosphoryl
maxim
respons
observ
within
min
follow
stimul
continu
h
fig
also
observ
alon
ifna
abl
induc
modest
phosphoryl
combin
treatment
caus
dramat
increas
phosphoryl
level
accord
induct
abovement
apoptosi
later
investig
akt
phosphoryl
stimul
lymphocyt
ifna
fac
analysi
nm
induc
transient
timedepend
increas
akt
phosphoryl
reach
maximum
level
min
return
close
basal
level
timepoint
fig
use
lower
concentr
nm
phosphoryl
peak
detect
min
incub
level
still
high
min
begin
stimul
data
shown
find
confirm
use
western
blot
analysi
fig
result
also
suggest
akt
phosphoryl
stronger
andor
ifna
present
fig
next
examin
activ
erk
kinas
follow
exposur
peripher
cell
ifna
exposur
lymphocyt
cell
nm
result
transient
increas
erk
phosphoryl
peak
min
exposur
fig
b
howev
assay
differ
combin
cytokin
test
incub
time
long
h
erk
phosphoryl
indistinguish
basal
activ
fig
indic
transient
erk
activ
alreadi
extinguish
howev
consid
assay
freshli
isol
human
cell
cultur
medium
alon
treat
ifna
combin
three
time
indic
cell
wash
analyz
fac
fac
perform
use
antibodi
specif
activ
mapk
result
shown
event
live
cell
gate
repres
least
three
independ
experi
b
western
blot
use
antibodi
left
perform
protein
deriv
human
cell
cultur
either
medium
alon
treat
ifna
time
indic
phosphoryl
quantifi
chemiluminesc
standard
blot
strip
reprob
antibodi
recogn
total
protein
actin
use
load
control
western
blot
band
quantif
right
cell
untreat
cultur
ifna
combin
three
indic
h
cell
lyse
phosphoryl
determin
western
blot
analysi
use
specif
antibodi
within
studi
reason
conclud
erk
activ
stronger
incub
occur
combin
andor
ifna
human
primari
lymphocyt
incub
ifna
togeth
differ
pathwayspecif
inhibitor
h
percentag
cell
death
determin
fac
analysi
fig
expect
cell
treat
ifna
inhibitor
show
notabl
increas
cell
death
compar
untreat
cell
medium
pertussi
toxin
inhibitor
gcoupl
protein
signal
wortmannin
inhibitor
induc
signific
increas
percentag
cell
death
compar
noinhibitor
group
hand
cell
treat
mapk
inhibitor
show
similar
level
cell
death
untreat
group
medium
indic
inhibitor
abl
revert
apoptosi
induc
ifna
final
inhibitor
mek
inhibitor
upstream
erk
modifi
level
cell
death
compar
noinhibitor
group
suggest
activ
erk
connect
induct
either
cell
death
surviv
addit
lymphocyt
treat
separ
inhibitor
increas
level
apoptosi
observ
data
shown
investig
antiapoptot
activ
upon
treatment
ifna
perform
western
blot
whole
cell
lysat
cell
use
antibodi
recogn
phosphoryl
total
shown
supp
fig
unabl
detect
chang
express
level
protein
whose
upregul
normal
link
presenc
stronger
antiapoptot
signal
howev
phosphoryl
present
cell
mediumonli
cell
suggest
treatment
activ
lymphocyt
block
least
part
antiapoptot
activ
phosphoryl
exert
activ
mapk
express
part
interferonstimul
gene
isg
respons
presenc
one
hallmark
immun
respons
viral
infect
selflimit
influenza
infect
process
high
level
detect
earli
stage
diseas
shortli
viru
clear
return
basal
level
even
though
marker
inflamm
repair
may
remain
elev
beyond
point
hand
situat
host
fail
control
viral
infect
level
togeth
isg
inflammatori
mediat
human
cell
cultur
medium
alon
treat
ifna
time
indic
cell
lyse
phosphoryl
level
akt
determin
western
blot
analysi
use
specif
antibodi
phosphoryl
quantifi
chemiluminesc
correct
total
akt
mapk
express
strip
blot
total
akt
actin
use
load
control
right
cell
untreat
treat
ifna
combin
indic
h
phosphoryl
determin
western
blot
analysi
use
specif
antiphosphoakt
antibodi
remain
highli
elev
throughout
process
possibl
caus
detriment
effect
mean
excess
immun
activ
cell
death
found
alon
modest
induc
apoptosi
accord
annexin
v
result
consequ
need
consid
addit
lymphocyt
activ
present
antivir
respons
vivo
unleash
full
potenti
sinc
show
true
biolog
effect
combin
cytokin
ifna
signal
statu
upon
treatment
combin
cytokin
focu
studi
argu
observ
downstream
signal
might
correspond
pure
respons
observ
effect
might
overlap
ifna
hand
note
presenc
cytokin
viral
infect
proven
fact
merit
scientif
attent
vivo
respons
mediat
alon
unlik
scenario
seventransmembranespan
domain
glycoprotein
receptor
coupl
gprotein
signal
pathway
bind
differ
chemokin
caus
downstream
activ
phospholipas
c
plc
kinas
c
format
phosphatidyl
increas
intracellular
calcium
ion
confirm
express
blood
lymphocyt
express
greatli
enhanc
treatment
fig
moreov
show
ifna
treatment
significantli
increas
express
cell
cell
supp
fig
howev
induc
chang
express
receptor
fig
observ
accord
previou
studi
reveal
express
lymphocyt
finetun
determin
presenc
certain
cytokin
would
appear
cell
undergo
apoptosi
caus
detect
increas
level
apoptosi
annexin
v
activ
fig
infa
alon
caus
modest
increas
apoptosi
dual
combin
plu
ifna
induc
substanti
greater
level
apoptosi
combin
tripl
combin
ifna
induc
highest
level
apoptosi
therefor
like
respons
undergo
apoptosi
chemotaxi
bestknown
effect
leukocyt
activ
signal
pathway
inhibit
pertussi
toxin
result
also
previou
studi
shown
ligand
induc
activ
mapk
fig
fig
erk
fig
howev
studi
small
molecul
kinas
inhibitor
unabl
link
conclus
kinas
induct
chemotaxi
lymphocyt
although
evid
involv
kinasemedi
signal
provid
smit
et
al
propos
chemotaxi
mediat
erk
akt
rather
phospholipas
cdepend
pathway
phosphatidylinositol
kinas
left
human
cell
cultur
medium
alon
treat
ifna
time
indic
cell
lyse
phosphoryl
level
erk
determin
western
blot
analysi
use
specif
antiphosphoerk
antibodi
phosphoryl
quantifi
chemiluminesc
correct
total
erk
express
strip
blot
total
erk
actin
use
load
control
right
cell
untreat
treat
ifna
combin
three
indic
h
phosphoryl
erk
determin
western
blot
analysi
use
specif
antiphosphoerk
antibodi
better
character
biolog
function
decid
explor
implic
induct
apoptosi
delin
signal
pathway
involv
process
result
show
contribut
trigger
apoptosi
activ
human
lymphocyt
shown
annexin
vpe
stain
fig
determin
whether
cell
death
analyz
whole
cell
lysat
lymphocyt
treat
ifna
presenc
activ
cleav
fragment
use
western
blot
probe
antibodi
recogn
procaspas
cleav
shown
fig
independ
treatment
ifna
result
appreci
overexpress
cleavag
highest
level
activ
result
combin
treatment
ifna
close
follow
treatment
interestingli
treatment
ifna
also
result
activ
much
lower
level
found
induc
sustain
phosphoryl
mapk
lymphocyt
fig
critic
mediat
apoptosi
also
particip
cellular
process
includ
inflamm
cell
differenti
cell
growth
moreov
studi
shown
apoptosi
abrog
inhibitor
fig
confirm
role
proapoptot
signal
incub
antiapoptot
identifi
mapk
substrat
direct
phosphoryl
mapk
prevent
exert
antiapoptot
function
allow
apoptot
process
occur
result
clearli
show
chang
express
level
upon
incub
lymphocyt
ifna
howev
phosphoryl
form
promin
chemokinetr
group
supp
fig
confirm
activ
mapk
induct
cell
surviv
also
critic
role
ligand
found
pertussi
toxin
dramat
increas
rate
apoptot
cell
treat
ifna
indic
antiapoptot
signal
gprotein
depend
fig
also
pretreat
cell
wortmannin
inhibitor
led
signific
increas
cell
death
fig
control
treat
either
pertussi
toxin
wormannin
show
increas
level
apoptosi
data
shown
rule
possibl
inhibitor
trigger
proapoptot
signal
directli
result
show
signal
play
critic
role
induct
prosurviv
signal
activ
lymphocyt
howev
exact
mechan
requir
investig
later
studi
activ
profil
akt
downstream
signal
mediat
akt
found
phosphoryl
lymphocyt
treat
togeth
andor
ifna
activ
found
transient
strong
akt
phosphoryl
detect
earli
min
stimul
bare
detect
min
fig
akt
crucial
cell
surviv
prolifer
gene
express
cell
migrat
prosurviv
effect
explain
least
part
fact
akt
inactiv
apoptot
factor
bad
direct
phosphoryl
downstream
activ
akt
close
relat
howev
addit
studi
requir
elucid
aspect
associ
involv
downstream
signal
mediat
mechan
akt
phosphoryl
rapidli
end
condit
would
necessari
sustain
akt
activ
previous
demonstr
loss
akt
signal
transient
activ
may
trigger
event
chemokineinduc
apoptosi
process
might
requir
promot
cell
migrat
also
induc
program
cell
death
cell
ligand
highli
express
mention
found
induc
transient
phosphoryl
erk
activ
lymphocyt
howev
pretreat
cell
mapk
kinas
mek
inhibitor
mek
upstream
regul
erk
alter
percentag
apoptot
cell
fig
suggest
activ
erk
play
relev
role
survivalapoptosi
signal
taken
togeth
result
highlight
relev
gcoupl
chemokin
receptor
signal
promot
surviv
lymphocyt
activ
mechan
downstream
signal
mediat
akt
mediat
death
cell
via
initi
proapoptot
signal
lymphocyt
untreat
treat
combin
ifna
follow
separ
preincub
follow
inhibitor
pertussi
toxin
inhibit
gprotein
coupl
signal
wortmannin
inhibitor
mapk
inhibitor
mek
inhibitor
h
later
percentag
cell
death
determin
use
annexin
vpe
apoptosi
detect
kit
bd
bioscienc
fig
propos
model
function
lymphocyt
activ
viral
infect
insult
produc
respons
interferon
signal
also
part
earli
immun
respons
augment
proport
lymphocyt
increas
respons
bind
receptor
transient
phosphoryl
akt
erk
particip
lymphocyt
activ
surviv
prolifer
differenti
chemotaxi
toward
infect
site
howev
addit
cosign
requir
maintain
longstand
activ
without
induc
apoptosi
caus
elimin
lowaffin
lymphocyt
subset
studi
vitro
experi
shown
induc
apoptosi
relev
proport
lymphocyt
fig
time
ifna
treatment
promot
cell
surviv
akt
activ
vivo
particip
activ
lymphocyt
viral
infect
prime
toward
phenotyp
induc
chemotaxi
toward
infect
tissu
howev
biolog
role
modul
apoptosi
surviv
lymphocyt
still
unclear
specul
may
help
focu
adapt
immun
respons
induc
apoptosi
lowaffin
lymphocyt
subset
includ
lymphocyt
initi
activ
later
lack
appropri
set
specif
costimul
signal
ensur
surviv
fig
addit
studi
term
cell
matur
antigen
select
phenotyp
requir
delin
featur
lymphocyt
posit
select
deplet
apoptosi
context
viral
infect
